Citations 1
Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021
Rothstein, Tanner E. , Rieke, Rachelle A., Mainella, Jill M., Mutchler, Melissa M., Patel, Robin , Patel, Robin , Cunningham, Scott A.
Antimicrobial Agents and Chemotherapy | March 21, 2022 | Volume: 66 | Issue: 4 | Pages: No page available
The epidemiology of macrolide resistance in Mycoplasma ( Mycoplasmoides ) pneumoniae in the United States is incompletely described. Using a PCR assay targeting common mutations associated with macrolide resistance in M. pneumoniae (23S rRNA gene, A2063G/A2064G), the frequency of macrolide resistance was estimated to be 10% based on analysis of 114 samples tested from January 2014 to September 2021 at Mayo Clinic Laboratories.